DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Rahme E, Nedjar H.
Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rheumatology (Oxford) 2007;
46: 435-438
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.